ITGAV and esophageal squamous cell carcinoma: Indomethacin, for instance, diminishes the growth and recurrence of esophageal squamous cell carcinoma (ESCC) by enhancing the E3 ligase synovial apoptosis inhibitor 1 (SYVN1)-mediated ubiquitination of integrin αv (ITGAV) [15].